|
Plasma-based exploratory biomarker analysis to evaluate GT0918 in a phase I/II study in mCRPC patients. |
|
|
|
|
Stock and Other Ownership Interests - Predicine |
|
|
|
Stock and Other Ownership Interests - Predicine |
Patents, Royalties, Other Intellectual Property - Predicine |
|
|
|
Stock and Other Ownership Interests - Predicine |
|
|
No Relationships to Disclose |
|
|
Employment - Suzhou Kintor Pharmaceuticals |
Stock and Other Ownership Interests - Suzhou Kintor Pharmaceuticals |
|
|
Employment - Suzhou Kintor Pharmaceuticals |
Leadership - Suzhou Kintor Pharmaceuticals |
Stock and Other Ownership Interests - Suzhou Kintor Pharmaceuticals |